Cargando…
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis
The notion that previous infection by Leishmania spp. in endemic areas leads to robust anti-Leishmania immunity, supports vaccination as a potentially effective approach to prevent disease development. Nevertheless, to date there is no vaccine available for human leishmaniasis. We optimized and asse...
Autores principales: | Cecílio, Pedro, Pérez-Cabezas, Begoña, Fernández, Laura, Moreno, Javier, Carrillo, Eugenia, Requena, José M., Fichera, Epifanio, Reed, Steven G., Coler, Rhea N., Kamhawi, Shaden, Oliveira, Fabiano, Valenzuela, Jesus G., Gradoni, Luigi, Glueck, Reinhard, Gupta, Gaurav, Cordeiro-da-Silva, Anabela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720812/ https://www.ncbi.nlm.nih.gov/pubmed/29176865 http://dx.doi.org/10.1371/journal.pntd.0005951 |
Ejemplares similares
-
Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant
por: Fernández, Laura, et al.
Publicado: (2021) -
Vector Saliva in Vaccines for Visceral Leishmaniasis: A Brief Encounter of High Consequence?
por: Kamhawi, Shaden, et al.
Publicado: (2014) -
Understanding Resistance vs. Susceptibility in Visceral Leishmaniasis Using Mouse Models of Leishmania infantum Infection
por: Pérez-Cabezas, Begoña, et al.
Publicado: (2019) -
Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
por: Brodskyn, Claudia I., et al.
Publicado: (2018) -
A defined subunit vaccine that protects against vector-borne visceral leishmaniasis
por: Duthie, Malcolm S., et al.
Publicado: (2017)